CCR2 AAA Pilot Study

Summary

CCR2 AAA Pilot Study is a clinical trial^[1].

Key Facts

• CCR2 AAA Pilot Study is in the country of United States^[2].
• CCR2 AAA Pilot Study's instance of is recorded as clinical trial^[3].
• CCR2 AAA Pilot Study's start time is recorded as +2020-10-07T00:00:00Z^[4].
• CCR2 AAA Pilot Study's end time is recorded as +2022-04-04T00:00:00Z^[5].
• CCR2 AAA Pilot Study's main subject is recorded as aneurysm^[6].
• CCR2 AAA Pilot Study's number of participants is recorded as {'unit': '1', 'amount': '+1'}^[7].
• CCR2 AAA Pilot Study's title is recorded as Targeted Molecular Probe for Abdominal Aortic Aneurysm Imaging and Therapy^[8].
• CCR2 AAA Pilot Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}^[9].
• CCR2 AAA Pilot Study's ClinicalTrials.gov ID is recorded as NCT04592991^[10].
• CCR2 AAA Pilot Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+75'}^[11].
• CCR2 AAA Pilot Study's research intervention is recorded as 12-crown-4^[12].
• CCR2 AAA Pilot Study's research intervention is recorded as mechanism of action^[13].
• CCR2 AAA Pilot Study's clinical trial phase is recorded as phase I clinical trial^[14].
• CCR2 AAA Pilot Study's research site is recorded as Washington University School of Medicine^[15].
• CCR2 AAA Pilot Study's research subject recruitment status is recorded as terminated^[16].
• CCR2 AAA Pilot Study's study type is recorded as interventional study^[17].